Medifast (MED) Tops Q2 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Unity Software stock soars 22% on strong Q3 beat, robust guidance
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $13.15 --0%
Financial Fact:
Provision for income taxes: 2.95M
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Provision for income taxes: 2.95M
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q2 EPS of ($0.28), $0.15 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $76.4 million versus the consensus estimate of $74.7 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loar Holdings Inc. (LOAR) Reports Q3 EPS of $0.39 ; Offers Guidance
- VisionChina (VISN) Tops Q3 EPS by 1c
- Hudson Pacific Properties (HPP) Misses Q3 EPS by 265c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
